ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Awards Grants To Physicians For Cancer Detection

August 2, 1991

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

House Republicans Move To Slash NIH Spending As Obama Calls For Renewed Investment in Science

February 18, 2011

Breast Cancer Risk Increases With Repeated CT Imaging

December 28, 2012

Bosnian Research Trying To Leave, Asks For More Calls

February 5, 1993